Delivery Order SPE2DB22D1202-SPE2DB25FVLA5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Pediarix HB vaccine in 0.5 mL vials with a ceiling value of $1,137.54. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. The award was made on a competitive basis without any set-aside designation, and performance will be...
- The U.S. Defense Logistics Agency awarded a $3,663.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pediarix vaccine vials (0.5mL) on August 7, 2025, with completion expected by August 8, 2025. This is a competitive award with no set-aside designation, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $1,299.69 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Pediarix 0.5 ML syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Pediarix 0.5 ML syringes, a pediatric vaccine product. This competitively awarded, non-set-aside contract is valued at $6,988.75 with a firm fixed price and an ultimate completion date of September 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.61 on August 8, 2025, for the supply of Pediarix 0.5 ML syringes. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 11, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's broader contractual...
- The Defense Logistics Agency awarded a delivery order valued at $12,360.60 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes, a pediatric vaccine combination product. This firm fixed price delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,326.85 to AmerisourceBergen Drug Corp for the supply of Pediarix (Pedvaxhib) vaccine in 0.5 mL vials. The contract, executed on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,920.27 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery of the pediatric vaccine product to support federal medical supply requirements. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pediarix HIB vaccine in 0.5 milliliter vials, with a ceiling value of $1,326.85 and an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under the company's larger...
- The Defense Logistics Agency awarded a $15,276.35 delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a single delivery of the pediatric vaccine product to support federal medical procurement needs. The award is not associated with a set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLA5Delivery Order
The Defense Logistics Agency awarded a $6,825.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Pediarix vaccine in 0.5 mL vials. This contract, which is non-set-aside and competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other government healthcare systems. The company's DLA Troop Support Medical prime contract functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of vaccines, brand-name and generic medications, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This delivery order for pediatric vaccines aligns with the broader mission of the DLA Medical Supply Chain to ensure adequate pharmaceutical and medical supply availability for military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/11/25 |